ATACseq on giredestrant-resistant ER+ breast cancer cell lines
Characterization of molecular features associated with giredestrant resistance in HR+ breast cancer cell line models Overall design: HR+ breast cancer cells were cultured in giredestrant for 2- or 4-months until they acquired resistance to giredestrant. Cells were then profiled via bulk RNA-seq and ATAC-seq.